Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

AI writes ICU updates for families: will it help?

NCT ID NCT06969196

First seen Jan 03, 2026 · Last updated Jun 20, 2026 · Updated 27 times

Summary

This pilot study tested whether AI-generated daily written summaries can help ICU clinicians communicate better with families. Clinicians edited the AI summaries before giving them to families. The study involved 27 participants and measured how acceptable and feasible this approach was for both clinicians and families.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ICU are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Rush University Medical Center

    Chicago, Illinois, 60612, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

AI-generated written summaries

What this could lead to

If successful, this could provide a time-saving way for ICU clinicians to keep families informed daily, potentially improving communication and reducing stress.

What could go wrong

This is a very small pilot study with only 27 participants, so results may not apply broadly. The AI summaries still need clinician editing, and the approach may not work for all communication challenges.

Conditions

The condition(s) this trial relates to.

Communication communication disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.